Related Experiment Videos
Stem cell transplantation: graft-mediated antileukemia effects
William J Hogan1, Hans Joachim Deeg
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Methods in Molecular Medicine
|December 9, 2004
Summary
Graft-versus-leukemia (GVL) activity enhances allogeneic stem cell transplants. Newer strategies combine reduced-intensity conditioning with donor leukocyte infusions to maximize GVL effects and minimize toxicity for more patients.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Graft-versus-leukemia (GVL) activity is crucial for allogeneic hematopoietic stem cell transplantation (aHCT) success.
- Advances allow GVL activity without myeloablative conditioning, expanding treatment eligibility.
- Reduced-intensity conditioning combined with donor leukocyte infusion (DLI) offers strategies to enhance GVL while reducing toxicity.
Purpose of the Study:
- To review evidence supporting GVL effects in aHCT.
- To discuss the influence of disease type on GVL activity.
- To explore the mechanisms underlying GVL.
Main Methods:
- Literature review of studies on GVL activity in aHCT.
- Analysis of strategies combining reduced-intensity conditioning and DLI.
- Examination of molecularly targeted agents in GVL therapy.
Main Results:
- GVL activity is a key factor in aHCT outcomes.
- Less toxic GVL strategies are emerging, benefiting older and sicker patients.
- New therapeutic possibilities arise from combining reduced-intensity conditioning, DLI, and targeted agents.
Conclusions:
- GVL activity is fundamental to successful aHCT.
- Innovations in conditioning regimens and adoptive immunotherapy are improving GVL efficacy and safety.
- Future therapies hold promise for less toxic, curative treatments for a wider patient population.